Kensington Capital Partners is a Canadian alternative investment firm founded in 1996, pursuing a diversified strategy across private markets including direct venture capital investments, co-investments, and a fund-of-funds program. Its latest fund, Kensington Venture Fund III, closed at $290 million in 2024.
Average disclosed round size is $26.7M (across 19 rounds with reported amounts).
Portfolio
20
Fund Size
$290M
Top Stage
Series C
Last 12 Mo
0
Team
Bogdan (Bo) Cenanovic
Senior Managing Director and Head of Private Equity
Alfred Chuang
Managing Director and Chief Financial Officer
Win Bear
Managing Director
Anthony Kubanin
Director, Technology and Operations
Lisa Sartor
Director
Rui Hu
Director, Marketing
Alan Lee
Vice President, Portfolio Analytics and Valuations
Patrick Dean
Vice President, Investment Finance
Richard Lipak
Vice President, Controller
Yiwei Zhang
Vice President, Investment Finance
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 ProteinQure | Series A | $11M | May 2025 |
 Avidbots | Series C | $70M | Sep 2022 |
 Borrowell | Unknown | $25M | Feb 2021 |
 LifeSpeak | Growth | $42M | Sep 2020 |
 Pela | Seed | $5M | Oct 2019 |
| MMojio | Series A | $40M | Feb 2019 |
 Vengo | Series A | $7M | Jan 2019 |
| MMojio | Series B | — | Nov 2017 |
 Mobile Klinik | Series B | $6.8M | Sep 2017 |
 Mojio Inc. | Series B | — | Jan 2017 |
 Clearpath Robotics | Series C | $30M | Oct 2016 |
 Clearpath | Series C | $30M | Oct 2016 |
 NatureBox | Series C | $30M | May 2015 |
| Vengo | Series A | $2M | Apr 2014 |
| ZZestFinance | Series C | $20M | Jul 2013 |
 Spare | Series B | — | — |
 iguazio | Growth | $24M | — |
 Figure 1 | Unknown | $10M | — |
 Vetster | Series B | $30M | — |
| Vetster | Series A | — | — |
 CheckSammy | Unknown | $45M | — |
| CCentric Health | Unknown | $30M | — |
 1NCE | Series C | $50M | — |
Top Co-Investors
Last updated: 8 September 2026